2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde

C40H64N8O9S — CID 140703029

IUPAC2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2OC(C)CC(N(C)C)C2O)[C@@H](CC=O)C[C@@H](C)CN[C@H](C)[C@H]2N(CCCCn3cc(-c4ncc(N)s4)nn3)C(=O)O[C@]12C
InChIInChI=1S/C40H64N8O9S/c1-10-30-40(7)35(48(39(53)57-40)15-12-11-14-47-21-28(44-45-47)36-43-20-31(41)58-36)26(6)42-19-22(2)17-27(13-16-49)34(24(4)32(50)25(5)37(52)55-30)56-38-33(51)29(46(8)9)18-23(3)54-38/h16,20-27,29-30,33-35,38,42,51H,10-15,17-19,41H2,1-9H3/t22-,23?,24+,25-,26-,27+,29?,30-,33?,34-,35-,38+,40-/m1/s1
InChIKeyIISVEFQFZJDGMS-GUWKEPBASA-N
MW833.07 g/mol
LogP3.54
Rot. Bonds12

About 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde

2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde (PubChem CID 140703029) has the molecular formula C40H64N8O9S and a molecular weight of 833.07 g/mol. Its IUPAC name is 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde.

Molecular Properties

Compound Name2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde
PubChem CID140703029
Molecular FormulaC40H64N8O9S
Molecular Weight833.07 g/mol
Exact Mass832.45
IUPAC Name2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2OC(C)CC(N(C)C)C2O)[C@@H](CC=O)C[C@@H](C)CN[C@H](C)[C@H]2N(CCCCn3cc(-c4ncc(N)s4)nn3)C(=O)O[C@]12C
InChIInChI=1S/C40H64N8O9S/c1-10-30-40(7)35(48(39(53)57-40)15-12-11-14-47-21-28(44-45-47)36-43-20-31(41)58-36)26(6)42-19-22(2)17-27(13-16-49)34(24(4)32(50)25(5)37(52)55-30)56-38-33(51)29(46(8)9)18-23(3)54-38/h16,20-27,29-30,33-35,38,42,51H,10-15,17-19,41H2,1-9H3/t22-,23?,24+,25-,26-,27+,29?,30-,33?,34-,35-,38+,40-/m1/s1
InChIKeyIISVEFQFZJDGMS-GUWKEPBASA-N
XLogP3.54
TPSA213.56 Ų
H-Bond Donors3
H-Bond Acceptors17
Rotatable Bonds12
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500833.07
LogP ≤ 53.54
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde?
The IUPAC name of 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde (CID 140703029) is 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde.
What is the SMILES notation for 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde?
The canonical SMILES for 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2OC(C)CC(N(C)C)C2O)[C@@H](CC=O)C[C@@H](C)CN[C@H](C)[C@H]2N(CCCCn3cc(-c4ncc(N)s4)nn3)C(=O)O[C@]12C.
What is the InChIKey of 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde?
The InChIKey is IISVEFQFZJDGMS-GUWKEPBASA-N. The full InChI is InChI=1S/C40H64N8O9S/c1-10-30-40(7)35(48(39(53)57-40)15-12-11-14-47-21-28(44-45-47)36-43-20-31(41)58-36)26(6)42-19-22(2)17-27(13-16-49)34(24(4)32(50)25(5)37(52)55-30)56-38-33(51)29(46(8)9)18-23(3)54-38/h16,20-27,29-30,33-35,38,42,51H,10-15,17-19,41H2,1-9H3/t22-,23?,24+,25-,26-,27+,29?,30-,33?,34-,35-,38+,40-/m1/s1.
What are the key properties of 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde?
2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde has a molecular weight of 833.07 g/mol, XLogP of 3.54, 12 rotatable bonds, 3 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1S,2R,5R,7R,8S,9R,11R,14R,15R)-16-[4-[4-(5-amino-1,3-thiazol-2-yl)triazol-1-yl]butyl]-8-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,11,14-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-9-yl]acetaldehyde is sourced from PubChem (CID 140703029), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).